Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation (NCT06499857)
🩺 Plain-English Summary (8th-Grade Level)
The goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might affect AF, atrial fibrillation severity, and whether it changes the risk of atrial fibrillation recurring after standard AF treatments.
Who can join: Review the eligibility criteria below.
Location: The University of Arizona College of Medicine- Phoenix — Phoenix, Arizona
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- The University of Arizona College of Medicine- Phoenix — Phoenix, Arizona
- University of Chicago — Chicago, Illinois
📞 Contact the Study Coordinator
Phone: (773) 702-3275
Email: spannain@bsd.uchicago.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overweight or Obesity
- A Study of LY4064912 in Healthy Participants and With Overweight or Obesity — Los Alamitos, California
- Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US — Walnut Creek, California
- PA Moves Trial - Patient Participants — Pittsburgh, Pennsylvania
- Berries, Inflammation, and Gut Microbiome — Chicago, Illinois
- Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women — Birmingham, Alabama
- The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control — Halifax, Nova Scotia
Explore by condition: All Overweight or Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.